The results showed that patients with high LC3 expression in both tissues (+/+) had a 1-, 3-, 5-, and 7-year cumulative incidence of HCC recurrence of 8.0%, 26.9%, 41.7%, and 53.5%, respectively. Here, MAP1LC3A is linked to hepatocellular carcinoma.